je.st
news
Boehringer Ingelheim Sees Advantages of Freshly Mixed Vaccine
2014-09-02 02:00:00| ThePigSite - Industry News
GERMANY - Boehringer Ingelheim Animal Health has decided to remain focused on freshly mixed Porcine Circovirus type 2 (PCV2)/ Mycoplasma hyopneumoniae (M.hyo) vaccines and not follow the development of a PCV2/M.hyo ready-to-use (RTU) vaccine combination.
Tags: mixed
advantages
sees
vaccine
Category:Agriculture and Forestry